Aedes aegypti areas to benefit

Oxitec will wait for a local non-binding referendum on the field trial in November before it begins its trial with the Florida Keys Mosquito Control District. The company is a subsidiary of Intrexon. The plan is to release genetically engineered mosquitoes into areas where the

Aedes aegypti mosquito is known to live, the species responsible for the spread of several vector-borne diseases.